Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - ferrous fumarate, quantity: 24.34 mg (equivalent: iron, qty 8 mg); ascorbic acid, quantity: 3.75 mg - pastille - excipient ingredients: ethylcellulose; malic acid; gelatin; glycerol; dibutyl sebacate; carnauba wax; vegetable oil; purified water; maltitol solution; steviol glycosides; colour; flavour - antioxidant/reduce free radicals formed in the body ; maintain/support energy levels ; maintain/support energy production ; relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; maintain/support blood health ; helps enhance/promote/increase absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - bictegravir sodium, quantity: 52.45 mg (equivalent: bictegravir, qty 50 mg); tenofovir alafenamide fumarate, quantity: 28.04 mg (equivalent: tenofovir alafenamide, qty mg); emtricitabine, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - biktarvy is indicated for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25 kg who are antiretroviral therapy (art)-na?ve or to replace the current antiretroviral regimen in those who are virologically-suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen at the start of therapy with no history of treatment failure, and no known substitutions associated with resistance to the individual components of biktarvy.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - bictegravir sodium, quantity: 52.45 mg (equivalent: bictegravir, qty 50 mg); tenofovir alafenamide fumarate, quantity: 28.04 mg (equivalent: tenofovir alafenamide, qty mg); emtricitabine, quantity: 200 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - biktarvy is indicated for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25 kg who are antiretroviral therapy (art)-na?ve or to replace the current antiretroviral regimen in those who are virologically-suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen at the start of therapy with no history of treatment failure, and no known substitutions associated with resistance to the individual components of biktarvy.

Israel - Inggeris - Ministry of Health

lapidot medical import and marketing ltd - iron sucrose - solution for injection - iron sucrose 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - ferrovin is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb (haemoglobin),serum ferritin, tsat (transferrin saturation), serum iron, etc.).

Filipina - Inggeris - FDA (Food And Drug Administration)

st. martin pharmaceutical laboratory - ferrous fumarate , folic acid - capsule - 183 mg (equivalent to 60 mg elemental iron) + 250 mcg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - ferrous fumarate - oral tablet - 322mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - ferrous fumarate - oral solution - 28mg/1ml

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - ferrous sulfate dried - oral tablet - 200mg

Filipina - Inggeris - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: n/a - ferrous fumarate, folic acid (vitamin b9) - capsule - 181.82 mg (equivalent to 60 mg elemental iron)/ 400 mcg

Filipina - Inggeris - FDA (Food And Drug Administration)

eba generisch trading inc.; importer: n/a; distributor: n/a - ferrous fumarate , folic acid (vitamin b9) - capsule - 181.82 mg (equivalent to 60 mg of elemental iron)/ 400 mcg